What is 340B? Exploring Pharmacist Contributions, its Important Role in Hospitals
June 29th 2023The impact of pharmacist on reducing medication expenses cannot be overstated as they leverage their medication management expertise within hospital settings through collaboration with the 340B program.
Read More
Study: Genentech’s Herceptin Lost Market Share After Introduction of First Trastuzumab Biosimilar
June 29th 2023Investigators found that the first biosimilar of trastuzumab, trastuzumab-anns (Kanjinti; Amgen), did maintain a strong and persistent advantage over the other 4 biosimilar entrants.
Read More
American Diabetes Association Highlights New Developments in Diabetes Technology
June 26th 2023The American Diabetes Association showcased advancements in diabetes technology revolving around improving glucose control devices and treating diabetic retinopathy at the 83rd Scientific Sessions.
Read More
Patients with ST-segment elevation myocardial infarction who are uninsured were not found to be transferred between facilities at a higher rate than insured patients, and the amount of transfers were instead based more on the capability of a facility to provide percutaneous coronary intervention in a timely fashion.
Read More